#1 Clinical Trials Search in Europe

Esketamine Hydrochloride

Esketamine hydrochloride, a potent anesthetic and analgesic, is being investigated in several clinical trials for its potential therapeutic benefits in various medical conditions. These trials aim to evaluate the drug’s efficacy, safety, and impact on patients’ quality of life across different medical fields, including psychiatry, pain management, and critical care.

Table of Contents

What is Esketamine Hydrochloride?

Esketamine hydrochloride, also known as Ketanest S or simply esketamine, is a medication that belongs to a class of drugs called dissociative anesthetics[1]. It is derived from ketamine and is considered to be more potent and have fewer side effects than its parent compound[2]. Esketamine works by affecting various receptors in the brain, particularly those involved in pain perception, mood regulation, and consciousness[3].

Medical Uses of Esketamine

Esketamine has several medical applications, including:

  • Treatment-resistant depression: Esketamine has been approved for use in patients with depression that hasn’t responded to other treatments[4].
  • Anesthesia: It is used as an anesthetic agent, particularly in situations where maintaining stable blood pressure is important[5].
  • Pain management: Esketamine is being studied for its potential in managing various types of pain, including chronic pain and pain associated with surgery[6].
  • Rett Syndrome: Research is being conducted to evaluate its effectiveness in treating symptoms of Rett Syndrome, a rare genetic neurological disorder[2].
  • Sepsis: Studies are exploring its potential anti-inflammatory effects in patients with sepsis, a life-threatening condition caused by the body’s response to infection[3].

How is Esketamine Administered?

Esketamine can be administered in several ways, depending on the medical condition being treated and the specific clinical situation:

  • Intravenous (IV) infusion: This is common in hospital settings, especially for anesthesia or pain management. The dose and duration can vary based on the patient’s needs[3].
  • Nasal spray: For treatment-resistant depression, esketamine may be given as a nasal spray under medical supervision[7].
  • Intramuscular injection: In some cases, esketamine might be injected into a muscle[8].

Effects of Esketamine

Esketamine can have various effects on the body and mind, including:

  • Rapid antidepressant action: Unlike traditional antidepressants that may take weeks to work, esketamine can provide relief from depressive symptoms much more quickly[4].
  • Pain relief: It has strong analgesic (pain-relieving) properties[6].
  • Cardiovascular stability: Esketamine can help maintain stable blood pressure during surgery, which is beneficial for certain patients[3].
  • Anti-inflammatory effects: Research suggests it may have anti-inflammatory properties, which could be beneficial in conditions like sepsis[3].
  • Dissociative effects: Patients may experience a feeling of detachment from their surroundings or themselves. This is usually temporary[1].

Potential Side Effects

Like all medications, esketamine can cause side effects. Some potential side effects include:

  • Nausea and vomiting[9]
  • Dizziness[9]
  • Changes in perception (feeling disconnected from your body or surroundings)[1]
  • Increased blood pressure[10]
  • Drowsiness[9]

It’s important to note that when used under medical supervision, many of these side effects can be managed effectively.

Ongoing Research

Esketamine is the subject of ongoing research in various areas:

  • Rett Syndrome: A study is investigating whether esketamine can improve symptoms in children with Rett Syndrome, a rare genetic disorder affecting brain development[2].
  • Sepsis: Researchers are exploring whether esketamine can reduce excessive inflammation and improve immune function in patients with sepsis[3].
  • Postoperative behavior in children: A study is examining if esketamine can reduce negative behavior changes in children after surgery[8].
  • Cancer-related pain and mood disorders: Research is being conducted on the effects of esketamine on postoperative pain, anxiety, and depression in cancer patients undergoing surgery[9].
  • Brain network function: Scientists are using brain imaging techniques to understand how esketamine affects brain networks, which could provide insights into its mechanism of action in conditions like schizophrenia[1].

These ongoing studies aim to expand our understanding of esketamine’s potential benefits and risks in various medical conditions.

Condition Study Focus Administration Method Key Outcomes Measured
Rett Syndrome Efficacy and safety in treating symptoms Intravenous infusion Rett Syndrome Behavior Questionnaire score, adverse events
Sepsis Effects on inflammation and immune function Intravenous infusion Serum inflammatory cytokines, lymphocyte subsets
Depression in Obese Patients Impact on depressive symptoms after bariatric surgery Intraoperative infusion Hamilton Depression Rating Scale, cognitive function
Chronic Pain due to Endometriosis Efficacy in treating chronic pelvic pain Intravenous infusion Numeric Rating Scale for pain, quality of life measures
Out-of-hospital Cardiac Arrest Neuroprotective effects Intravenous or intraosseous bolus Neuron-specific enolase levels, neurological outcomes

FAQ

  • What is Esketamine hydrochloride? Esketamine hydrochloride is a potent anesthetic and analgesic drug that is being studied for its potential therapeutic benefits in various medical conditions. It is a form of ketamine that acts on the brain's glutamate system.
  • What conditions are being studied using Esketamine hydrochloride? Clinical trials are investigating Esketamine hydrochloride for conditions such as Rett syndrome, sepsis, depression in obese patients undergoing bariatric surgery, chronic pain due to endometriosis, and as a potential neuroprotective agent following out-of-hospital cardiac arrest.
  • How is Esketamine hydrochloride administered in these trials? The administration of Esketamine hydrochloride varies depending on the study. It may be given intravenously, as a nasal spray, or as part of anesthesia during surgery. The dosage and duration of treatment also differ based on the specific trial and condition being studied.
  • Are there any potential side effects of Esketamine hydrochloride? While side effects can vary, some trials are monitoring for adverse events such as nausea, dissociative effects, changes in blood pressure, and heart rate. The safety profile is being carefully evaluated in each study.
  • How long do these clinical trials typically last? The duration of clinical trials for Esketamine hydrochloride varies widely. Some studies involve a single dose and short-term follow-up, while others may last several months to evaluate long-term effects and outcomes.

Ongoing Clinical Trials on Esketamine Hydrochloride

  • Study on the Effects of Ketamine and Esketamine on Brain Activity in Healthy Volunteers

    Recruiting

    1 1
    Investigated drugs:
    Austria

  • Study on Esketamine and Diphenhydramine for Treating Depression and Negative Symptoms in Schizophrenia Patients

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria

  • Study on Esketamine Hydrochloride and Sodium Chloride for Patients with Severe Acute Brain Injury

    Recruiting

    1 1 1
    Investigated drugs:
    Denmark

  • Study on the Effects of Esketamine Hydrochloride and Propofol for Patients After Cardiac Arrest

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Esketamine for Treating Chronic Pain in Endometriosis Patients

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Comparison of esketamine hydrochloride mouthwash and intravenous esketamine to reduce pain from oral mucositis in patients undergoing hematopoietic stem cell transplantation

    Not yet recruiting

    1 1 1
    Investigated drugs:
    The Netherlands

  • Study on Premedication with Ketamine or Fentanyl for Patients with Respiratory Distress Syndrome Receiving Surfactant Treatment

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

  • Study on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany Italy Spain

  • A study to compare the safety of ketamine hydrochloride and esketamine in healthy men for the treatment of depression

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study Comparing Low-Dose Esketamine and Ketamine for Severe Acute Pain in Emergency Department Patients

    Not recruiting

    1 1 1 1
    Investigated drugs:
    France

Glossary

  • Esketamine hydrochloride: A potent anesthetic and analgesic drug that is a form of ketamine, acting on the brain's glutamate system. It is being studied for various medical conditions.
  • Rett syndrome: A rare genetic neurological disorder that affects brain development, causing a progressive loss of motor skills and speech.
  • Sepsis: A life-threatening condition that occurs when the body's response to infection causes widespread inflammation and organ dysfunction.
  • Endometriosis: A condition where tissue similar to the lining of the uterus grows outside the uterus, causing pain and potential fertility issues.
  • Out-of-hospital cardiac arrest (OHCA): A sudden loss of heart function that occurs outside of a hospital setting, often leading to death if not treated promptly.
  • Neuroprotective: Describing a substance or treatment that protects nerve cells from damage, degeneration, or impairment of function.
  • Hypoxic-ischemic brain injury (HIBI): Brain damage that occurs when the brain doesn't receive enough oxygen or blood flow.
  • N-Methyl-D-Aspartate (NMDA) receptor: A type of glutamate receptor in nerve cells that plays a crucial role in synaptic plasticity and memory function.
  • Neuron-specific enolase (NSE): A protein found primarily in neurons and neuroendocrine cells, used as a marker for neuronal damage.
  • Modified Rankin Score (mRS): A scale used to measure the degree of disability in patients who have suffered a stroke or other neurological injuries.
  • Cerebral Performance Categories (CPC): A scale used to assess neurological outcomes after cardiac arrest, ranging from 1 (good cerebral performance) to 5 (brain death).

References

  1. https://clinicaltrials.gov/study/NCT01394757
  2. https://clinicaltrials.gov/study/NCT06199700
  3. https://clinicaltrials.gov/study/NCT04843982
  4. https://clinicaltrials.gov/study/NCT06199011
  5. https://clinicaltrials.gov/study/NCT05092152
  6. https://clinicaltrials.gov/study/NCT06161805
  7. https://clinicaltrials.gov/study/NCT00847418
  8. https://clinicaltrials.gov/study/NCT06579937
  9. https://clinicaltrials.gov/study/NCT04613869
  10. https://clinicaltrials.gov/study/NCT06467513